Johnson & Johnson's COVID-19 vaccine will be back in circulation this weekend after the U.S. Center for Disease Control and Prevention (CDC) accepted an advisory panel's decision that the benefits of the shots outweigh the risks, the LA Times website reports today (April 24, 2021).
The CDC's action lifted a 10-day pause that went into effect April 13 after federal safety monitors received reports of rare but potentially deadly blood clotting disorders in 15 people who received the J&J vaccine.
The restart means that the single-dose shots will return to mass vaccination drives, pharmacies, and doctors' offices immediately.
No comments:
Post a Comment